BETA

IPO registrations (S-1, F-1) · Registrants

BIODESIX INC

SEC CIK
1439725 · filings on EDGAR ↗
Registration
Form S-1, first filed 2020-10-02, last 2024-05-24; 2 initial registrations, 5 amendments
Outcome
Final prospectus filed 2020-10-29; declared effective 2020-10-27
Industry (SIC)
Services-Medical Laboratories 8071
Incorporated in
DE
Business address
919 WEST DILLON ROAD, Louisville, CO 80027
EIN
20-3986492
Ticker
BDSX (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
BIODESIX INC on the corporate pages

Offering terms

Proposed price range
$17.00–$19.00 per share (S-1/A filed 2020-10-26)
Final price
$18.00 per share, within the range (424B4 filed 2020-10-29, an initial public offering)
Shares sold
4,000,000
Gross proceeds
$72,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol BDSX
Lead underwriters
Morgan Stanley; William Blair
Syndicate
Canaccord Genuity; BTIG

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2020-10-02S-1S-1 (registration)BIODESIX INC0001193125-20-262422 ↗
2020-10-09S-1/AS-1/A (amendment)BIODESIX INC0001193125-20-266992 ↗
2020-10-14S-1/AS-1/A (amendment)BIODESIX INC0001193125-20-268763 ↗
2020-10-21S-1/AS-1/A (amendment)BIODESIX INC0001193125-20-273369 ↗
2020-10-26S-1/AS-1/A (amendment)BIODESIX INC0001193125-20-275630 ↗
2020-10-27EFFECTEFFECT (declared effective)BIODESIX INC9999999995-20-002996 ↗
2020-10-29424B4424B4 (final prospectus)BIODESIX INC0001193125-20-281042 ↗
2021-11-29EFFECTEFFECT (declared effective)BIODESIX INC9999999995-21-004502 ↗
2022-06-17EFFECTEFFECT (declared effective)BIODESIX INC9999999995-22-001817 ↗
2024-04-23S-1S-1 (registration)BIODESIX INC0001193125-24-107051 ↗
2024-05-24S-1/AS-1/A (amendment)BIODESIX INC0001193125-24-147047 ↗
2024-06-04EFFECTEFFECT (declared effective)BIODESIX INC9999999995-24-001736 ↗
2024-11-12EFFECTEFFECT (declared effective)BIODESIX INC9999999995-24-003462 ↗
2024-11-12EFFECTEFFECT (declared effective)BIODESIX INC9999999995-24-003463 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2020-10-26S-1/Aregistration statement$17.00–$19.00$18.004,166,667$75,000,006Nasdaq BDSX4primary document; range, price sentence, shares headline, proceeds computed, cover names 4document ↗
2020-10-29424B4final prospectus$18.004,000,000$72,000,000Nasdaq BDSX4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Cowie Robin HarperOfficerCFO, Sec'y & Treasurer; CFO, Sec?y & Treasurer342020–2026
Franchi Jean M.Director132020–2026person page Fuzzy
Georgantas Robert William IIIDirector,Officer; OfficerChief Scientific Officer; SVP, Rsrch & Trans'l Science102020–2022
Hutton ScottDirector,OfficerPresident & CEO322020–2026
MASSARANY HANYDirector162020–2026
O'Kane KieranOfficerChief Commercial Officer302020–2026
PATIENCE JOHNDirector,Officer,TenPercentOwner; Director,Other; Director,TenPercentOwner,Other; Director,TenPercentOwnerOtherChairman272020–2026
Pestano Gary AnthonyOfficerChief Development Officer312020–2026
SCHULER JACK WDirector,TenPercentOwner; TenPercentOwner,Other482020–2026
Strobeck MatthewDirector192020–2026
Watts Charles MDirector162020–2025
Siurek Ryan HOfficerChief Accounting Officer112021–2023
Kayyem Jon FaizDirector142021–2026person page Fuzzy
Kennedy Lawrence T. JrDirector,TenPercentOwner; TenPercentOwner122022–2026person page Fuzzy
Vazquez ChrisOfficerChief Accounting Officer212023–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2019-12-20BIODESIX INCBiotechnology$31,000,000$16,000,000322
2019-08-22BIODESIX INCBiotechnology$10,000,000$4,902,500261
2018-10-23BIODESIX INCBiotechnology$27,524,500$17,511,736331
2018-07-16BIODESIX INCBiotechnology$7,987,428$7,987,42812
2018-05-08BIODESIX INCBiotechnology$10,282,858$5,282,162221
2018-03-09BIODESIX INCBiotechnology$1,500,000$1,500,00011
2017-04-24BIODESIX INCBiotechnology$25,332,143$13,165,482171
2016-11-30BIODESIX INCBiotechnology$15,700,000$5,121,632121
2016-07-27BIODESIX INCBiotechnology$7,208,382$6,114,729151
2016-02-12BIODESIX INCBiotechnology$22,202,324$17,756,512241
2015-10-08BIODESIX INCBiotechnology$20,000,000$8,609,000181
2015-06-23BIODESIX INCBiotechnology$15,148,000$10,390,000241
2015-01-13BIODESIX INCBiotechnology$18,158,000$11,285,000191
2014-01-13BIODESIX INCBiotechnology$16,362,306$14,407,686261

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationBiodesix Inc.COState business registriesname and state
Business registrationBiodesix, Inc.COState business registriesname and state
Business registrationBIODESIX, INC.COState business registriesEIN (EXACT, as the state registration reports it)
Business registrationBIODESIX, INC.COState business registriesname and state
Federal award recipientBIODESIX, INCCOFederal spending (USAspending)name and state
Form D issuerBIODESIX INCCOForm D private offeringsCIK (EXACT)
Lobbying clientBIODESIXCOFederal lobbying (LDA)name and state
Lobbying clientBIODESIXCOFederal lobbying (LDA)name and state
Lobbying clientBIODESIX, INC.COFederal lobbying (LDA)name and state
Lobbying registrantBIODESIXCOFederal lobbying (LDA)name and state
Patent assigneeBiodesix, Inc.COPatents (USPTO)name and state
SEC filerBIODESIX INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerBiodesix, Inc.COTrademarks (USPTO)name and state
Form 5500 plan sponsorBIODESIX, INC.EIN (EXACT)
Person pageJean M FranchiPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageJon Faiz KayyemPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageLawrence T Kennedy JrPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Services-Medical Laboratories, CO first:

More with this interest.

In other datasets, the same topic (Health) in CO:

Interests: Services-Medical Laboratories · Health